In the UK the NIHR defines public involvement in research as research being carried out ‘with’ or ‘by’ members of the public rather than ‘to’, ‘about’ or ‘for’ them.
The NIHR Patient Engagement in Clinical Development Service connects life science companies with patients who want to help shape and improve the design and, ultimately, the delivery of commercial clinical research.
It is available to all life sciences industries, including Clinical Research Organisations (CROs).
Why choose the NIHR?
Benefit from our brand Charities and patients engage with the trusted brands of the NIHR and the NHS
Build better relationships We act as an independent intermediary to broker and develop relationships on your behalf
The network approach NIHR has an extensive network across multiple therapeutic areas to identify relevant patient groups
Achieve equity We’ll provide guidance on the application of nationally accepted remuneration for patient involvement activities
Bespoke to you Every study is unique and our support will be tailored to your individual requirements
Continuous support We will assist you every step of the way and be your primary point of contact
Supported by the ABPI This service is aligned with the ABPIs Code of Conduct
Involving patients right at the beginning of the clinical development process has the potential to significantly improve study design and delivery. As well as providing an opportunity to gain a better understanding of the patient’s needs, it is also a chance for protocols to be considered in real life scenarios, issues to be identified, and problems to be resolved before a study opens for recruitment.
This will ultimately result in:
Better study design
Better participant recruitment
Better participant retention
Better protocol adherence
Typical patient engagement activities include:
Identifying research priorities
Reviewing study protocols
Simulating the study delivery approach
Commenting on, and supporting the development of patient information sheets and other related materials
Feedback on patient access and outreach strategies
Watch this video (under 4 minutes) to find out more about patient perspectives on being involved in designing clinical research. Jennifer Preston concludes the video by summarising how the NIHR piloted a patient involvement service. Please note this video was created in May 2018 and the Patient Engagement in Clinical Development service is now an established part of the package of support that the NIHR offers the life science industry. It is available to all life science companies and Contract Research Organisations (CROs).
Get in touch
If you are not ready to submit your study and you would like to talk to a member of our team about our Patient Engagement in Clinical Development service please contact:
The NIHR defines public involvement in research as research being carried out ‘with’ or ‘by’ members of the public rather than ‘to’, ‘about’ or ‘for’ them. In the UK we tend to use the term 'involvement', however, internationally the life science industry often uses the term 'engagement'. The NIHR Patient Engagement in Clinical Development Service provides a national framework for patients to become involved specifically in commercial clinical research, ideally before a protocol is finalised.
The National Institute for Health Research has today reaffirmed its long-standing commitment to transparency by supporting the Health Research Authority’s new transparency strategy, which aims to ensure information about health and social care research is made publicly available in a way that benefits patients, researchers and policy makers.
The NIHR has highlighted its continuing commitment to ensuring patients, carers and the public have a say in and help to shape health and care research during the COVID-19 pandemic, producing new commitments on how to adapt.